Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 06-2024 | 12-2023 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,554 | 8,591 | 10,516 | 10,631 | 15,926 |
| Marketable Securities | N/A | N/A | 1,500 | 4,000 | 3,750 |
| Other current assets | 3,067 | 1,932 | 2,077 | 3,941 | 3,723 |
| TOTAL | $7,621 | $10,523 | $14,093 | $18,572 | $23,399 |
| Non-Current Assets | |||||
| PPE Net | 101 | 18 | 26 | 42 | 86 |
| Intangibles | 100 | 99 | 102 | 92 | 44 |
| TOTAL | $201 | $117 | $128 | $134 | $130 |
| Total Assets | $7,822 | $10,640 | $14,221 | $18,706 | $23,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 764 | 1,078 | 592 | 2,742 | 548 |
| TOTAL | $1,544 | $1,078 | $1,564 | $2,742 | $3,254 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,544 | $1,078 | $1,564 | $2,742 | $3,254 |
| Shareholders' Equity | |||||
| Common Shares | 2,027 | 2,014 | 2,014 | 2,014 | 2,014 |
| Retained earnings | -121,477 | -118,180 | -115,085 | -111,778 | -107,467 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $6,278 | $9,562 | $12,657 | $15,964 | $20,275 |
| Total Liabilities And Equity | $7,822 | $10,640 | $14,221 | $18,706 | $23,529 |